Elevance Health, Inc.
ELVNYSECIK 1156039FinancialsFiscal year ends Dec 31
All transactions: 13
Non-derivative transactions reported on Forms 4, newest first. Purchases and sales (codes P and S) are open-market trades; the other codes are grants, exercises, withholding and gifts. The reported price is as stated on the form, not a market price.
What these mean: insiders, Form 4, transaction codes, Rule 10b5-1 plans.
| Date | Insider | Transaction | Shares | Reported price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-10-22 | Kaye MarkEVP & CFO, Officer | Sale | 273 | $447.19 | $122.1k | Form 4 |
| 2026-10-22 | Kaye MarkEVP & CFO, Officer | Sale | 827 | $446.05 | $368.9k | Form 4 |
| 2026-10-22 | Kaye MarkEVP & CFO, Officer | Sale | 160 | $444.85 | $71.2k | Form 4 |
| 2026-10-22 | Kaye MarkEVP & CFO, Officer | Sale | 440 | $443.81 | $195.3k | Form 4 |
| 2026-10-22 | Kaye MarkEVP & CFO, Officer | Sale | 480 | $442.61 | $212.5k | Form 4 |
| 2026-10-22 | Kaye MarkEVP & CFO, Officer | Sale | 2,343 | $441.34 | $1.0m | Form 4 |
| 2026-10-22 | Kaye MarkEVP & CFO, Officer | Sale | 1,720 | $440.44 | $757.6k | Form 4 |
| 2026-10-22 | Kaye MarkEVP & CFO, Officer | Sale | 1,160 | $439.25 | $509.5k | Form 4 |
| 2026-10-22 | Kaye MarkEVP & CFO, Officer | Sale | 240 | $438.22 | $105.2k | Form 4 |
| 2026-10-22 | Kaye MarkEVP & CFO, Officer | Sale | 560 | $437.07 | $244.8k | Form 4 |
| 2026-10-22 | Kaye MarkEVP & CFO, Officer | Sale | 1,660 | $436.20 | $724.1k | Form 4 |
| 2026-10-22 | Kaye MarkEVP & CFO, Officer | Sale | 321 | $435.25 | $139.7k | Form 4 |
| 2026-10-22 | Kaye MarkEVP & CFO, Officer | Sale | 400 | $434.00 | $173.6k | Form 4 |
Source: SEC EDGAR, Forms 4. Last ingested by Listed: Oct 24, 2026, 15:05 ET. Listed shows no prices and gives no investment advice.